603998 Share Price Performance
CN¥11.97
-0.73 (-5.75%)
Price CN¥11.97
Share PriceCN¥11.97
Hunan Fangsheng Pharmaceutical Co., Ltd.'s (SHSE:603998) Low P/E No Reason For Excitement
Mar 20
Hunan Fangsheng Pharmaceutical Co., Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
603998 Community Narratives
There are no narratives available yet.
Recent 603998 News & Updates
Hunan Fangsheng Pharmaceutical's (SHSE:603998) Earnings Are Weaker Than They Seem
Nov 04The Market Doesn't Like What It Sees From Hunan Fangsheng Pharmaceutical Co., Ltd.'s (SHSE:603998) Earnings Yet
Jun 06Earnings Troubles May Signal Larger Issues for Hunan Fangsheng Pharmaceutical (SHSE:603998) Shareholders
Apr 30Hunan Fangsheng Pharmaceutical Co., Ltd. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Oct 24, 2025
- Earnings per share (EPS)
- 0.66
- Gross Margin
- 69.68%
- Net Profit Margin
- 16.90%
- Debt/Equity Ratio
- 30.4%
Hunan Fangsheng Pharmaceutical Co., Ltd. Competitors
Snowflake Analysis
About 603998
- Founded
- 2002
- Employees
- 1807
- CEO
- WebsiteView website
Hunan Fangsheng Pharmaceutical Co., Ltd. engages in research, develops, produces, and sells traditional Chinese medicine industry and chemical pharmaceutical products in China. The company offers pharmaceutical manufacturing; and provides cardiovascular and cerebrovascular drugs, skeletal muscle system drugs, orthopedic drugs, respiratory drugs, pediatric drugs, gynecological drugs, and anti-infective drugs. The company's main products include Xuesetong dispersible tablets, Xuesetong tablets, Garcinia bone-strengthening tablets, Dieda Huoxue capsules, Lysine Vitamin B12 granules, Cefuroxime tablets, Jinying capsules, Pudilan anti-inflammatory tablets, Xiaoer Jingxing cough granules, Ezetimibe tablets, Xuanqi bone-strengthening tablets, Qiangli Loquat Paste (honey-refined), and Qiangli Loquat Dew and others. It also offers other businesses, such as medical services, pharmaceutical commerce, and drug sales. The company was founded in 2002 and is based in Changsha, China.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Chinese Market Performance
- 7 Days: 1.8%
- 3 Months: 18.3%
- 1 Year: 24.1%
- Year to Date: 26.2%
In the last week, the market is up 1.8% led by Industrials sector. As for the past 12 months, the market is up 24%. Looking forward, earnings are forecast to grow by 27% annually. Market details ›